Long term treatment with ranirestat, an aldose reductase inhibitor, suppresses diabetic neuropathy and cataract formation in rats

被引：0
|
作者：
Matsumoto, Takafumi
Toyosawa, Kaoru
Furutani, Yasur
Bril, Vera
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A125 / A125
页数：1
相关论文
共 50 条
  • [21] ONE-YEAR TREATMENT WITH THE ALDOSE REDUCTASE INHIBITOR, PONALRESTAT, IN DIABETIC NEUROPATHY
    ZIEGLER, D
    MAYER, P
    RATHMANN, W
    GRIES, FA
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1991, 14 (01) : 63 - 74
  • [22] Effects of aldose reductase inhibitor in diabetic rats
    Nagai, T
    Sekizuka, E
    Tsukada, K
    Shimizu, T
    Minamitani, H
    Hokari, R
    Oshio, C
    [J]. PROCEEDINGS OF THE 20TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 20, PTS 1-6: BIOMEDICAL ENGINEERING TOWARDS THE YEAR 2000 AND BEYOND, 1998, 20 : 3098 - 3099
  • [23] Fidarestat - SNK-860 - Treatment of diabetic neuropathy - Aldose reductase inhibitor
    不详
    [J]. DRUGS OF THE FUTURE, 2001, 26 (03) : 297 - 297
  • [24] GP-1447, an Inhibitor of Aldose Reductase, Prevents the Progression of Diabetic Cataract in Rats
    Kawakubo, Ken
    Mori, Asami
    Sakamoto, Kenji
    Nakahara, Tsutomu
    Ishii, Kunio
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2012, 35 (06) : 866 - 872
  • [25] The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats
    Shimoshige, Y
    Ikuma, K
    Yamamoto, T
    Takakura, S
    Kawamura, I
    Seki, J
    Mutoh, S
    Goto, T
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (11): : 1395 - 1399
  • [26] EFFECTS OF AN ALDOSE REDUCTASE INHIBITOR, SORBINIL, ON EXPERIMENTAL DIABETIC NEUROPATHY AND SUGAR CATARACTS IN RATS
    ISHIKO, J
    SUZUKI, M
    OHTSUKI, I
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 40 : P244 - P244
  • [27] Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat
    Hotta, N.
    Kawamori, R.
    Atsumi, Y.
    Baba, M.
    Kishikawa, H.
    Nakamura, J.
    Oikawa, S.
    Yamada, N.
    Yasuda, H.
    Shigeta, Y.
    [J]. DIABETIC MEDICINE, 2008, 25 (07) : 818 - 825
  • [28] Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: An Indian perspective
    Sharma, S. R.
    Sharma, Nalini
    [J]. ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2008, 11 (04) : 231 - 235
  • [29] Effects of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy and gastroparesis
    Okamoto, H
    Nomura, M
    Nakaya, Y
    Uehara, K
    Saito, K
    Kimura, M
    Chikamori, K
    Ito, S
    [J]. INTERNAL MEDICINE, 2003, 42 (08) : 655 - 664
  • [30] CLINICAL-TRIAL OF AN ALDOSE REDUCTASE INHIBITOR IN DIABETIC NEUROPATHY
    HANDELSMAN, DJ
    TURTLE, JR
    [J]. DIABETES, 1981, 30 (06) : 459 - 464
12345